At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial
In Brief
A clinical study evaluating Carotid endarterectomy (CEA), Carotid Stenting (CAS), and 2 other interventions for Carotid Stenosis. Completed, enrolled 2,486 participants across 167 sites in 5 countries.
Detailed Summary
Carotid revascularization for primary prevention of stroke (CREST-2) is two independent multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1:1 ratio to endarterectomy versus no endarterectomy and another will randomize patients in a 1:1 ratio to carotid stenting with embolic protection versus no stenting. Medical management will be uniform for all randomized treatment groups and will be centrally directed.
Study Details
Timeline
Interventions
Carotid endarterectomy
Carotid stenting
Intensive Medical Management alone - no CEA
Intensive Medical Management alone - no CAS